Summary
Overview
Work History
Education
Skills
Additional Qualifications
Timeline
Generic

Kamal K Bhalla

Associate Vice President - Sales & Marketing

Summary

With over 29 years of therapy experience, I have successfully driven growth, executed strategic initiatives, built high-performing teams, and launched new brands while transforming businesses. Skilled in identifying new business opportunities and fostering cross-functional collaboration to deliver excellence in profitable business management. Consistently grown businesses within organizational policies by tracking sales strategies in defined therapy areas, positively impacting market share and elevating brand rankings. Seeking to align with a professional organization to leverage expertise, knowledge, and relationships for driving growth opportunities. Goal is to secure roles promoting professional development, cultivating strong teams, and leading individuals to success.

Overview

31
31
years of professional experience

Work History

AVP-Sales & Marketing

Cadila Pharmaceuticals
12.2024 - Current
  • Company Overview: Turnover: 1,265 Cr.
  • Segment: Acute (Ortho)
  • Period: December 9, 2024, onwards.
  • Annual sales: 65 Cr.
  • Growth: 11%.
  • PBT: 16%.
  • Expanded the geography in the West and North.
  • Registered a growth of 12.5% in MAT on June 25.
  • Consolidated position crossing mark in CVM as per IQVIA MAT June.
  • Improved rank from 13th MAT on June 24 to 10th MAT on June 25.

Associate Vice President-Sales

Indoco Remedies Pvt Ltd
07.2023 - 12.2024
  • Company Overview: Turnover: 1,200 Cr.
  • Segments: Mass (Acute)
  • Period: July 1, 2023 – December 1, 2024.
  • Annual sales: 312 Cr.
  • Growth (%): 7%
  • Stabilized the TN and Northern states (UP, DLH, Raj) in terms of attrition, and added the incremental productivity of 3 Cr.
  • Business year 2024-2025 is at 100% with 560 FSO on budget.
  • The first-ever Cyclopam achieved 13 Cr. with 33% growth.
  • Cital (Group) achieved 2.60 Crs. with 30% growth O/L and 35% growth in Rxn.
  • Started the field operation in Srinagar, Kashmir.
  • Actively engaged Pedia for TOT and built KOL and KBL in UP.
  • Associated with ENT for the different workshops in otology and temporal bone dissection, followed by hands-on.

General Manager - Sales

Hetero Healthcare Limited
08.2022 - 07.2023
  • Company Overview: Turnover: 675 Cr.
  • Segments: Mass (Acute)
  • Period: August 2022 - July 2023.
  • Annual sales: 180 Cr.
  • Growth (%): 2%
  • Filled the long-pending 96 vacancies across the country, especially in the northern and southern regions.
  • Created the system to monitor the efforts and ROI of highly invested customers.
  • Focused on the performance of mixed products alongside the legacy brands, and drive Etoro/Linowin and Vetory Group.
  • Drove Fluvir as the first brand to detail at each customer, resulting in an addition of 1 crore over the previous months.
  • Division has driven growth of 2% with 96% YTD business.

National Sales Manager

Zydus Life science Ltd.
10.2012 - 08.2022
  • Company Overview: Turnover: 7,207 Cr.
  • Segments: Mass (Major Ortho) / Pain Management.
  • Period: October 2012 – August 2022.
  • Annual sales: 288 Cr.
  • Growth (%): 9%.
  • Organized platform OA, 'Ortho Academica': Understanding the core of Ortho.
  • Actively engaged delegates and faculty through various platforms (hands-on workshop, CME, cadaveric WS).
  • Successfully launched the brand extension of Ocid, being Ocid L. The contribution of Ocid has increased to 2.7 Cr/month.
  • Successfully absorbed the brand Actibile (UDCA) and drove it to 114% and 44% growth until it existed in the division.
  • Successfully handled the assignment in Gujrat, struggling with attrition and performance.
  • Nucoxia contributes 11 Cr per month to the total business.
  • Aggressively adopted and executed virtual faculties, and engaged our customers online through Ortho TV.
  • Ensured the implementation of ZFL 2.0 (Efforts) successfully, with 100% compliance.
  • Successfully managed the unionized issue of WB, and contributed 17% growth with 100% achievement.

Zonal Business Manager

Emcure Pharmaceuticals Ltd.
01.1999 - 10.2012
  • Company Overview: Turnover: 5,263 Cr.
  • Segments : Chronic (CVD) & Acute (Gynec)
  • Period: January 1999 - October 2012.
  • Annual sales: 17.40 Cr + 7.40 Cr.
  • Growth (%): 18%.
  • Successfully launched NUCRON in Punjab.
  • S-Numlo, Metpure XL, Atorec, and Nucoril contributed 90% in 50 Lac/Month in the geography of Punjab.
  • Internally promoted at four levels: BO, ABM, RBM, and ZBM.
  • Orofer XT, Orofer-S, and Emenzen-D.
  • Successfully launched Exhep (LMWH) among gynecologists. Contributed to 25 lac per month.
  • Actively engaged customers in various activities and the platform.
  • Simultaneously managed a team of 12 TSEs for the Injectable Division, with a volume of 60 lac per month.
  • Developed and promoted 14 team members handling responsibilities individually in different roles.

Medical Representative

Aventis Pharmaceuticals
01.1995 - 01.1999
  • I started my career in 1995 with HMR (currently known as Aventis), based in Erode (TN), and subsequently worked for Knoll Magnus (a joint venture of Novo Nordisk) in Lucknow to promote Human Mixtard (PF) and Novopen from 1997 to 1999.

Education

Bachelors - science, Zoology/Botany/Chemistry

No Degree - Executive Course

IIM Ahmedabad
Ahmedabad, India
04.2001 -

Skills

Operations management

Additional Qualifications

Executive course of IIM - Ahmedabad

Timeline

AVP-Sales & Marketing

Cadila Pharmaceuticals
12.2024 - Current

Associate Vice President-Sales

Indoco Remedies Pvt Ltd
07.2023 - 12.2024

General Manager - Sales

Hetero Healthcare Limited
08.2022 - 07.2023

National Sales Manager

Zydus Life science Ltd.
10.2012 - 08.2022

No Degree - Executive Course

IIM Ahmedabad
04.2001 -

Zonal Business Manager

Emcure Pharmaceuticals Ltd.
01.1999 - 10.2012

Medical Representative

Aventis Pharmaceuticals
01.1995 - 01.1999

Bachelors - science, Zoology/Botany/Chemistry

Similar Profiles

CREATE PROFILE
Kamal K BhallaAssociate Vice President - Sales & Marketing